Business ❯ Pharmaceuticals

Market Analysis

Company Performance Stock Performance Drug Approval Product Development Revenue Trends Drug Sales Clinical Trials Financial Outlook Drug Development Sales Growth Revenue Growth Sales Forecast Competition Stock Ratings Vaccine Sales Product Portfolio Earnings Forecast Obesity Drug Market US Market Sales Forecasts Financial Projections Revenue Forecast

FDA Approves Darzalex Faspro as First Therapy for High-Risk Smoldering Multiple Myeloma

The ruling follows a Phase 3 trial that cut the risk of progression or death by 51% versus active monitoring.

FDA Approves Papzimeos as First Therapy for Adult Recurrent Respiratory Papillomatosis

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.